447 related articles for article (PubMed ID: 3121426)
1. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
3. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
4. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
5. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
Haissaguerre M; Warin JF; Goldrach S; Le Métayer P; Guillem JP; Blanchot P
Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
8. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
Song Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
10. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
11. [Radiofrequency ablation in the treatment of supraventricular tachyarrhythmia. Experience with 500 consecutive patients].
Iturralde Torres P; Colín Lizalde L; Kershenovich S; García Moreno J; Marroquín O; Cordero A; Lara S; González Hermosillo JA
Arch Inst Cardiol Mex; 1995; 65(6):503-19. PubMed ID: 8948685
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
Nishino T
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
[TBL] [Abstract][Full Text] [Related]
14. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
17. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
[TBL] [Abstract][Full Text] [Related]
18. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
Finzi A; Potenza S; Guenzati G
G Ital Cardiol; 1990 Dec; 20(12):1161-7. PubMed ID: 2128068
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
20. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
Kim SS; Lal R; Ruffy R
Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]